Clinical trials
Terminated Phase 2 Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
113 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 2 |
| 2003 | 5 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 9 |
| 2007 | 13 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 7 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 113 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gynecologic Oncology Group | 10 |
| M.D. Anderson Cancer Center | 7 |
| National Cancer Institute (NCI) | 7 |
| Dana-Farber Cancer Institute | 3 |
| Masonic Cancer Center, University of Minnesota | 3 |
| Mayo Clinic | 3 |
| Beth Israel Deaconess Medical Center | 2 |
| Bracco Diagnostics, Inc | 2 |
| Eli Lilly and Company | 2 |
| NYU Langone Health | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 113 |
| Fallopian Tube Neoplasms | 31 |
| Carcinoma, Ovarian Epithelial | 26 |
| Breast Neoplasms | 11 |
| Neoplasms | 11 |
| Pancreatic Neoplasms | 8 |
| Colorectal Neoplasms | 7 |
| Sarcoma | 7 |
| Melanoma | 6 |
| Recurrence | 6 |
Trials
Showing 1 to 25 of 113. Each trial links to its page on Pharma Observatory.
13 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.